medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Number 620

<< Back Next >>

Rev Med Cos Cen 2016; 73 (620)

Carcinoma de sitio primario desconocido

Vargas CDA

Language: Spanish
References: 10
Page: 583-586
PDF size: 179.53 Kb.


ABSTRACT

Carcinomas of unknown primary have a big impact on the patient’s survival rate, this being that it has been proven that their molecular genetic bases are different from those primary cancers where origin is known, tending to behave differently and making treatment unspecific. Clinical evaluation has improved greatly due to merit on diagnostic development and empirical treatment, thus significantly increasing the median patient survival rate.


REFERENCES

  1. Acosta, R. R., González, J. C., Ramos, C. S., & Velázquez, R. T. (2015). Cáncer metastásico de origen primario desconocido. Revista Archivo Médico de Camagüey, 9(2).

  2. Casciato, D; Territo, M. (2013). Manual de Oncología Clínica (7ma. Edición). Wolters Kluwer Health, Barcelona España, pagina 493- 505.

  3. DeVita V., Lawrence T., & Rosenberg S., (2011). CANCER PRINCIPLES & PRACTICE OF ONCOLOGY (10ma. Ed.) United States of America; Wolters Kluwer Health, pagina 2516 – 2536.

  4. Fizazi, K., Greco, F. A., Pavlidis, N., Pentheroudakis, G., & ESMO Guidelines Working Group. (2011). Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and followup. Annals of oncology,22(suppl 6), vi64-vi68.

  5. Hainsworth, J. D., Rubin, M. S., Spigel, D. R., Boccia, R. V., Raby, S., Quinn, R., & Greco, F. A. (2013). Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. Journal of Clinical Oncology, 31(2), 217-223.

  6. Longo,L.,Jamenson, L., Fauci, A., Hause,S.& Loscalzo,J. (2015). HARRISON’S PRINCIPLES OF INTERNAL MEDICINE (19 EDITION). McGraw-Hill Education, United States. Pág. 120e1.

  7. Ross, J. S., Wang, K., Gay, L., Otto, G. A., White, E., Iwanik, K., & Stephens, P. J. (2015). Comprehensive genomic profiling of carcinoma of unknown primary site: new routes to targeted therapies. JAMA Oncology, 1(1), 40-49.

  8. Senra Armas, L. A., & Menéndez Pérez, R. (2014). Identificación de tumor primario en pacientes con metástasis como forma de presentación de cáncer.Revista Cubana de Medicina, 53(4), 402- 416.

  9. Vikeså, J., Møller, A. K., Kaczkowski, B., Borup, R., Winther, O., Henao, R., & Nielsen, F. C. (2015). Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin. BMC cancer, 15(1), 151.

  10. Varadhachary, G. & Raber, M. Cancer of Unknown Primary Site (August 21, 2014). The New England Journal Medicine, 371:757-765.




2020     |     www.medigraphic.com